Figure 3. Fragment‐based drug discovery assays.

(A) Summary of amino acid targeting moieties with the reactive warheads highlighted in red. (B) Overview of a reactive fragment covalently binding to a protein target of interest and how LC–MS and LC–MS/MS contribute to the measurement of binding affinity, localization of covalently bound residue as well as kinetic and competition studies.